Pain Medicine, Interventional Pain Medicine · Portland, OR
NPI
1245325893
Since 2006
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9155 SW Barnes Rd, Suite 934
Portland, OR, 97225
Phone (503) 292-7005
Groups this clinician bills Medicare through
Medicare paid, 2024
$187K
4,637 services
Medicare patients, 2024
321
Average age 70
Drug cost, 2024
$705K
5,236 prescriptions
Company payments, 2025
$63.07
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Navnit Kaur-Jayaram was code J1010 (injection, methylprednisolone acetate, 1 mg), 980 times for 25 patients. In total Navnit Kaur-Jayaram billed 4,637 services in 63 codes, and Medicare paid $187K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 980 | 25 | $0.10 | $99.59 |
| 99214 Office E&M - Established | Office | 243 | 158 | $86.44 | $21K |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 187 | 70 | $5.50 | $1,029 |
| 80305 Drug Tests | Office | 165 | 162 | $12.01 | $1,981 |
| J0475 Injection, baclofen, 10 mg | Office | 129 | 15 | $130.37 | $17K |
| 99205 Office E&M - New | Office | 70 | 70 | $164.43 | $12K |
| 27096 Joint Injection | Office | 58 | 42 | $167.69 | $9,726 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 56 | 56 | $24.72 | $1,384 |
| 99215 Office E&M - Established | Office | 52 | 44 | $130.60 | $6,791 |
| 64635 Destruction by Neurolytic Agent - Back | Office | 52 | 48 | $479.35 | $25K |
| 64636 Destruction by Neurolytic Agent - Back | Office | 50 | 46 | $265.23 | $13K |
| 99213 Office E&M - Established | Office | 50 | 41 | $47.62 | $2,381 |
| 64493 Nerve Block Injection - Back | Office | 45 | 27 | $188.92 | $8,502 |
| 62323 Nerve Block Injection - Back | Office | 41 | 28 | $198.32 | $8,131 |
| 64494 Nerve Block Injection - Back | Office | 38 | 22 | $94.61 | $3,595 |
By year: 2022 $134K for 4,020 services; 2023 $132K for 3,192 services; 2024 $187K for 4,637 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 165 | 162 | $12.01 | $1,981 |
Medicare prescription drug claims, 2024
In 2024, the drug Navnit Kaur-Jayaram prescribed most often to Medicare patients was Morphine Sulfate Er (Morphine Sulfate), with 1,900 prescriptions and refills. In total Navnit Kaur-Jayaram wrote 5,236 Medicare prescriptions that cost $705K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Morphine Sulfate Er Morphine Sulfate | 1,900 | 1,902 | 209 | $62K |
| Fentanyl Generic | 456 | 456 | 47 | $53K |
| Methadone Hcl Generic | 415 | 418 | 58 | $11K |
| Oxycontin Oxycodone Hcl | 328 | 328 | 35 | $358K |
| Oxycodone Hcl Generic | 288 | 288 | 92 | $2,035 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 197 | 197 | 57 | $2,314 |
| Xtampza Er Oxycodone Myristate | 175 | 175 | 24 | $146K |
| Tramadol Hcl Generic | 153 | 153 | 32 | $883 |
| Gabapentin Generic | 144 | 197 | 29 | $3,879 |
| Duloxetine Hcl Generic | 140 | 185 | 30 | $1,959 |
| Pregabalin Generic | 112 | 158 | 26 | $4,058 |
| Tizanidine Hcl Generic | 111 | 131 | 18 | $1,174 |
| Baclofen Generic | 62 | 93 | 16 | $1,091 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 58 | 58 | 23 | $369 |
| Methocarbamol Generic | 55 | 56 | 12 | $788 |
Brand drugs: 574 claims; generic drugs: 4,662 claims; opioid claims: 4,116.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Navnit Kaur-Jayaram $63.07 ($63.07 in general payments such as food, travel and fees) from 3 companies. The largest payer was Vertex Pharmaceuticals Incorporated with $29.4.
| Company | Payments | Amount |
|---|---|---|
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $29.4 |
| Piramal Critical Care | 1 | $16.99 |
| Saluda Medical Americas, Inc. | 1 | $16.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.